ReviewCritical care (London, England)2026
The six phases of prolonged veno-venous extracorporeal membrane oxygenator support: a conceptual framework.
Review in Critical care (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mitochondrial dysfunction in ARDS: unraveling the regulatory networks and therapeutic opportunities.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Veno-venous extracorporeal membrane oxygenation (V-V ECMO) is a complex and invasive intervention used increasingly in the management of severe respiratory failure. Once established, the management of prolonged V-V ECMO support involves balancing priorities of lung protection, prevention of pulmonary complications, sedation weaning and safe reduction in ECMO support. These occur variably as the pulmonary pathology resolves and ECMO support is reduced. Evidence based strategies to assist clinicians during prolonged V-V ECMO support are lacking, with the majority of literature focussing on ventilation strategies following ECMO initiation and the criteria for separation from V-V ECMO once liberation is considered safe. Practice is largely clinician and institution dependent with significant heterogeneity. There are numerous questions which remain unanswered regarding the prioritisation and strategies for safe V-V ECMO weaning. This review aimed to provide a novel conceptual framework to assist clinicians by dividing prolonged V-V ECMO support into six phases: ultra-lung-protective, lung protective, transition to spontaneous breathing, liberation trial, decannulation and post decannulation support. We reviewed existing literature and identified knowledge gaps for future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.